On August 13, after several reschedules, the disciplinary hearing was held to decide on the subject. Silva's defense argued that a tainted sexual enhancement supplement was the root of the two failed tests for drostanolone and also appealed to mistakes in the NSAC testing procedures, pointing to a pair of drug tests, one on Jan. 19 and one after the fight, which Silva passed. He admitted to using both benzodiazepines the night prior to the fight as therapy to control stress and help him sleep. Silva's team was unable to explain the presence of androsterone in the Jan. 9 test. The commission rejected the defense and suspended him for one year retroactive to the date of the fight, as the current guidelines were not in effect at the time of the failed tests. He was also fined his full win bonus, as well as 30% of his show money, totaling $380,000. His victory was overturned to a no contest.  Diaz's hearing was delayed until September.  On September 14, Diaz was suspended for five years and also fined 33% of his show purse totaling $165,000.  Following his appeal four months later in January 2016, the suspension and fine were reduced to 18 months and $100,000 respectively. 
Other significant adverse effects of testosterone supplementation include acceleration of pre-existing prostate cancer growth in individuals who have undergone androgen deprivation; increased hematocrit , which can require venipuncture in order to treat; and, exacerbation of sleep apnea .  Adverse effects may also include minor side-effects such as acne and oily skin, as well as, significant hair loss and/or thinning of the hair, which may be prevented with 5-alpha reductase inhibitors ordinarily used for the treatment of benign prostatic hyperplasia , such as finasteride .  Exogenous testosterone may also cause suppression of spermatogenesis , leading to, in some cases, infertility.  It is recommended that physicians screen for prostate cancer with a digital rectal exam and prostate-specific antigen (PSA) level before starting therapy, and monitor PSA and hematocrit levels closely during therapy.